Export 27 results:
Filters: Author is Alexander,J. W.  [Clear All Filters]
Boardman RE, Alloway RR, Alexander JW, Buell JF, Cardi M, First MR, et al. African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression. Am J Transplant. 2005;5(2):356-65.
Rogers CC, Alloway RR, Buell JF, Boardman R, Alexander JW, Cardi M, et al. Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression. Transplantation. 2005;80(1):26-33.
Rogers CC, Hanaway M, Alloway RR, Alexander JW, Boardman RE, Trofe J, et al. Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy. Transplant Proc. 2005;37(2):795-7.
Rogers CC, Alloway RR, Boardman R, Trofe J, Hanaway MJ, Alexander JW, et al. Global cardiovascular risk under early corticosteroid cessation decreases progressively in the first year following renal transplantation. Transplant Proc. 2005;37(2):812-3.
Woodle ES, Susskind B, Alloway RR, Hanaway MJ, Thomas M, Buell J, et al. Histocompatibility testing predicts acute rejection risk in early corticosteroid withdrawal regimens. Transplant Proc. 2005;37(2):809-11.
Buell JF, Lee L, Martin JE, Dake NA, Cavanaugh TM, Hanaway MJ, et al. Laparoscopic donor nephrectomy vs. open live donor nephrectomy: a quality of life and functional study. Clin Transplant. 2005;19(1):102-9.
Woodle ES, Alloway RR, Buell JF, Alexander JW, Munda R, Roy-Chaudhury P, et al. Multivariate analysis of risk factors for acute rejection in early corticosteroid cessation regimens under modern immunosuppression. Am J Transplant. 2005;5(11):2740-4.
Alloway RR, Hanaway MJ, Trofe J, Boardman R, Rogers CC, Hanaway MJ, et al. A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience. Transplant Proc. 2005;37(2):802-3.